| Literature DB >> 33445065 |
Tadaaki Hanatani1, Naoko Takasu2.
Abstract
In Japan, induced pluripotent stem cell (iPSC) Stock Project has started from 2013. The goal of the Project is to manufacture and release clinical-grade HLA homozygous iPSC lines that can cover almost the entire of Japanese population. We show the summary of the cell lines distributed, test results for quality control and future plans.Entities:
Year: 2020 PMID： 33445065 DOI： 10.1016/j.scr.2020.102033
Source DB: PubMed Journal: Stem Cell Res ISSN： 1873-5061 Impact factor: 2.020